Malwina Mejer | Senior Economist
Copenhagen Economics

Malwina Mejer is a Senior Economist at Copenhagen Economics, where she has worked since 2022 as part of the Healthcare and Life Sciences team. She applies economic analysis to regulatory and policy questions in the life sciences sector, supporting decision-making for policymakers and industry. Her work centres on rare disease policy, including the economic impact of regulatory incentives, early diagnosis, access to orphan medicinal products, and procurement. Malwina leads and contributes to multi-stakeholder projects, working with industry, patient organisations, and the research community to support evidence-based policymaking. Prior to joining Copenhagen Economics, Malwina held research and policy roles at Bruegel and the European Commission. She holds a PhD in Economics and Management from the Université libre de Bruxelles.